Patents by Inventor Gary T. Elliott

Gary T. Elliott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tetrahydropyrano-indole derivatives
    Patent number: 7314886
    Abstract: Provided herein are indole derivatives, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
    Type: Grant
    Filed: October 1, 2004
    Date of Patent: January 1, 2008
    Assignee: Cephalon, Inc.
    Inventors: Qi Chao, Gary T. Elliott, Lorenzo Leoni, Mimi K. Phillips
  • Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
    Patent number: 6800613
    Abstract: Methods and compositions for treating or ameliorating diseases and other conditions, such as infectious diseases, autoimmune diseases and allergies are provided. The methods employ mono- and disaccharide-based compounds for selectively stimulating immune responses in animals and plants.
    Type: Grant
    Filed: May 18, 2001
    Date of Patent: October 5, 2004
    Assignee: Corixa Corporation
    Inventors: David H. Persing, Richard Thomas Crane, Gary T. Elliott, J. Terry Ulrich, Michael J. Lacy, David A. Johnson, Jory R. Baldridge, Rong Wang
  • Prophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
    Publication number: 20040147480
    Abstract: Methods and compositions for treating or ameliorating diseases and other conditions, such as infectious diseases, autoimmune diseases and allergies are provided. The methods employ mono- and disaccharide-based compounds for selectively stimulating immune responses in animals and plants.
    Type: Application
    Filed: January 13, 2004
    Publication date: July 29, 2004
    Applicant: Corixa Corporation
    Inventors: David H. Persing, Richard T. Crane, Gary T. Elliott, J. Terry Ulrich, Michael J. Lacy, David A. Johnson, Jory R. Baldridge, Rong Wang
  • Mono- and disaccharides for the treatment of nitric oxide related disorders
    Patent number: 6699846
    Abstract: Methods for treating diseases or conditions modulated or ameliorated by nitric oxide, particularly ischemia and reperfusion injury, are provided, using glycolipids structurally related to monophosphoryl lipid A but with notable reduction in proinflammatory and pyrogenic activity.
    Type: Grant
    Filed: March 14, 2001
    Date of Patent: March 2, 2004
    Assignee: Corixa Corporation
    Inventors: Gary T. Elliott, David Johnson, Patricia Weber, Greg Sowell
  • Phophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
    Publication number: 20030105032
    Abstract: Methods and compositions for treating or ameliorating diseases and other conditions, such as infectious diseases, autoimmune diseases and allergies are provided. The methods employ mono- and disaccharide-based compounds for selectively stimulating immune responses in animals and plants.
    Type: Application
    Filed: April 22, 2002
    Publication date: June 5, 2003
    Inventors: David H. Persing, Richard Thomas Crane, Gary T. Elliott, J. Terry Ulrich, Michael J. Lacy, David A. Johnson, Jory R. Baldridge, Rong Wang
  • Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
    Publication number: 20020077304
    Abstract: Methods and compositions for treating or ameliorating diseases and other conditions, such as infectious diseases, autoimmune diseases and allergies are provided. The methods employ mono- and disaccharide-based compounds for selectively stimulating immune responses in animals and plants.
    Type: Application
    Filed: May 18, 2001
    Publication date: June 20, 2002
    Inventors: David H. Persing, Richard Thomas Crane, Gary T. Elliott, J. Terry Ulrich, Michael J. Lacy, David A. Johnson, Jory R. Baldridge, Rong Wang
  • Phosphoglycolipid and methods for its use
    Patent number: 6399590
    Abstract: The invention concerns a novel phosphoglycolipid compound. The compound of the subject invention is 2-Deoxy-6-O-[2-deoxy-4-O-phosphono-3-O-[(R)-3-tetradecanoyloxytetradecanoyl]-2-[(R)-3-octadecanoyloxytetradecanoylamino]-&bgr;-D-glucopyranosyl]-2-[(R)-3-hexadecanoyloxytetradecanoylamino]-D-glucopyranose and pharmaceutically acceptable salts thereof. The compound is not immunoreactive, not pyrogenic, not toxic but is active in ameliorating tissue damage due to ischemia/reperfusion injury. Methods for using the subject compound to protect against reversible and irreversible damage due to ischemia/reperfusion injury are also disclosed.
    Type: Grant
    Filed: August 10, 2001
    Date of Patent: June 4, 2002
    Assignee: Corixa Corporation
    Inventors: Gary T. Elliott, Patricia A. Weber, C. Gregory Sowell
  • Mono-and disaccharides for the treatment of nitric oxide related disorders
    Publication number: 20020045586
    Abstract: Methods for treating diseases or conditions modulated or ameliorated by nitric oxide, particularly ischemia and reperfusion injury, are provided, using glycolipids structurally related to monophosphoryl lipid A but with notable reduction in proinflammatory and pyrogenic activity.
    Type: Application
    Filed: March 14, 2001
    Publication date: April 18, 2002
    Inventors: Gary T. Elliott, David Johnson, Patricia A. Weber, C. Gregory Sowell
  • Phosphoglycolipid and methods for its use
    Publication number: 20020013291
    Abstract: The invention concerns a novel phosphoglycoilpid compound. The compound of the subject invention is 2-Deoxy-6-O-[2-deoxy-4-O-phosphono-3-O-[(R)-3-tetradecanoyloxytetradecanoyl]-2-[(R)-3-octadecanoyloxytetradecanoylamino]-&bgr;-D-glucopyranosyl]-2-[(R)-3-hexadecanoyloxytetradecanoylamino]-D-glucopyranose and pharmaceutically acceptable salts thereof. The compound is not immunoreactive, not pyrogenic, not toxic but is active in ameliorating tissue damage due to ischemia/reperfusion injury. Methods for using the subject compound to protect against reversible and irreversible damage due to ischemia/reperfusion injury are also disclosed.
    Type: Application
    Filed: August 10, 2001
    Publication date: January 31, 2002
    Inventors: Gary T. Elliott, Patricia A. Weber, C. Gregory Sowell
  • Phosphoglycolipid and methods for its use
    Patent number: 6013640
    Abstract: The invention concerns a novel phosphoglycolipid compound. The compound of the subject invention is 2-Deoxy-6-O-[2-deoxy-4-O-phosphono-3-O-[(R)-3-tetradecanoyloxytetradecanoy l]-2-[(R)-3-octadecanoyloxytetradecanoylamino]-.beta.-D-glucopyranosyl]-2-[ (R)-3-hexadecanoyloxytetradecanoylamino]-D-glucopyranose and pharmaceutically acceptable salts thereof. The compound is not immunoreactive, not pyrogenic, not toxic but is active in ameliorating tissue damage due to ischemia/reperfusion injury. Methods for using the subject compound to protect against reversible and irreversible damage due to ischemia/reperfusion injury are also disclosed.
    Type: Grant
    Filed: August 21, 1998
    Date of Patent: January 11, 2000
    Assignee: Ribi ImmunoChem Research, Inc.
    Inventors: Gary T. Elliott, Patricia A. Weber, C. Gregory Sowell
  • Method and composition for ameliorating tissue damage due to ischemia and reperfusion
    Patent number: 5286718
    Abstract: A method of inhibiting tissue damage in warm blooded animals related to reperfusion of tissues after extended periods of ischemia is presented. The method comprises treatment prior to a planned ischemic event or up to six hours after an unplanned ischemic event with an effective amount of monophosphoryl lipid A or 3-deacylated monophosphoryl lipid A. Pharmaceutical compositions for the treatment are also disclosed.
    Type: Grant
    Filed: December 31, 1991
    Date of Patent: February 15, 1994
    Assignee: RIBI Immunochem Research, Inc.
    Inventor: Gary T. Elliott